These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20176908)

  • 41. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
    Sherwin J; Heath T; Watt K
    Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation.
    Ye Q; Wang Q; Chen W; Zhang R; Chen Z; Li P; Zhang X; Zhan Q; Wang C
    J Clin Pharm Ther; 2022 Oct; 47(10):1608-1618. PubMed ID: 35716048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population Pharmacokinetics of Phenobarbital in Neonates and Infants on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Thibault C; Massey SL; Abend NS; Naim MY; Zoraian A; Zuppa AF
    J Clin Pharmacol; 2021 Mar; 61(3):378-387. PubMed ID: 32960986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
    Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment.
    Hanberg P; Öbrink-Hansen K; Thorsted A; Bue M; Tøttrup M; Friberg LE; Hardlei TF; Søballe K; Gjedsted J
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individual Meropenem Clearance in Infants on ECMO and CVVHDF is Difficult to Predict: A Case Report and Review of the Literature.
    Jabareen A; Nassar L; Karasik M; Efrati E; Hadash A; Kassis I; Kurnik D
    Pediatr Infect Dis J; 2022 Feb; 41(2):117-120. PubMed ID: 34966143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.
    Lima-Rogel V; Medina-Rojas EL; Del Carmen Milán-Segovia R; Noyola DE; Nieto-Aguirre K; López-Delarosa A; Romano-Moreno S
    J Clin Pharm Ther; 2008 Jun; 33(3):295-306. PubMed ID: 18452417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation.
    Yang S; Noh H; Hahn J; Jin BH; Min KL; Bae SK; Kim J; Park MS; Hong T; Wi J; Chang MJ
    Sci Rep; 2017 Nov; 7(1):16276. PubMed ID: 29176598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.
    Merchan LM; Hassan HE; Terrin ML; Waites KB; Kaufman DA; Ambalavanan N; Donohue P; Dulkerian SJ; Schelonka R; Magder LS; Shukla S; Eddington ND; Viscardi RM
    Antimicrob Agents Chemother; 2015 Jan; 59(1):570-8. PubMed ID: 25385115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation.
    Pokorná P; Šíma M; Vobruba V; Tibboel D; Slanař O
    Perfusion; 2018 May; 33(1_suppl):80-86. PubMed ID: 29788839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants.
    Tang BH; Wu YE; Kou C; Qi YJ; Qi H; Xu HY; Leroux S; Huang X; Zhou Y; Zheng Y; Jacqz-Aigrain E; Shen AD; Zhao W
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose Optimization of Meropenem in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Cardiac Patients: Pharmacokinetic/Pharmacodynamic Modeling.
    Kang S; Yang S; Hahn J; Jang JY; Min KL; Wi J; Chang MJ
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.
    Shekar K; Fraser JF; Smith MT; Roberts JA
    J Crit Care; 2012 Dec; 27(6):741.e9-18. PubMed ID: 22520488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis).
    Sharma SK; Srivastava AK
    J Vet Sci; 2006 Jun; 7(2):119-22. PubMed ID: 16645334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review.
    Yalcin N; Sürmelioğlu N; Allegaert K
    BMJ Paediatr Open; 2022 Nov; 6(1):. PubMed ID: 36437518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience.
    Jacobs RF; Kearns GL
    Diagn Microbiol Infect Dis; 1989; 12(1):93-9. PubMed ID: 2653717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations.
    Aardema H; Bult W; van Hateren K; Dieperink W; Touw DJ; Alffenaar JC; Zijlstra JG
    J Antimicrob Chemother; 2020 Feb; 75(2):441-448. PubMed ID: 31697336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction.
    Sime FB; Lassig-Smith M; Starr T; Stuart J; Pandey S; Parker SL; Wallis SC; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study.
    Alihodzic D; Wicha SG; Frey OR; König C; Baehr M; Jarczak D; Kluge S; Langebrake C
    Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meropenem pharmacokinetics during extracorporeal membrane oxygenation and continuous haemodialysis: a case report.
    Saito J; Shoji K; Oho Y; Aoki S; Matsumoto S; Yoshida M; Nakamura H; Kaneko Y; Hayashi T; Yamatani A; Capparelli E; Miyairi I
    J Glob Antimicrob Resist; 2020 Sep; 22():651-655. PubMed ID: 32417590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.